EBR Systems, Inc.ASX: EBR

EBR Submits TGA ARTG Application for WiSE System

· Issued by EBR Systems, Inc. via ASX

Filed with ASX · · 3 pages · English

Summary by 6ix AI

EBR Systems, Inc. has submitted an application to the Therapeutic Goods Administration for the inclusion of the WiSE System on the Australian Register of Therapeutic Goods. This submission is a significant step in the company's regulatory and commercialization strategy, following the grant of Priority Review Determination by the TGA. If approved, the WiSE System would provide Australian heart failure patients with access to a unique wireless pacing option that does not require traditional leads. The application is supported by prior FDA approval in the U.S., aiming to expand EBR's market presence beyond the United States.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

ASX ANNOUNCEMENT 20 October 2026 EBR Submits TGA ARTG Application for WiSE® System Key Highlights • EBR Systems has formally submitted its application to the TGA for inclusion of the WiSE® System on the ARTG • The application is expected to be assessed under the Priority Review Determination...

EBR Systems, Inc. on 6ix

Earlier from EBR Systems

Later from EBR Systems

All EBR Systems news releases